NovoLet® Acceptance Study Within the Hospital Practise in Indonesia

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 1; Diabetes; Diabetes Mellitus, Type 2

Treatments: Drug: insulin human

Study type: Observational

Funder types: Industry

Identifiers

NCT01492205

NOPEN3-1887

Details and patient eligibility

About

This study is conducted in Asia. The aim of this study is to evaluate the overall acceptance of healthcare professionals (nurses and doctors) to the NovoLet® system used in a hospital environment.

Enrollment: 203 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Type 1 diabetes
• Type 2 diabetes
• Likely to be hospitalised and require insulin therapy

Trial design

203 participants in 1 patient group

Human insulin

Treatment:

Drug: insulin human